Law360, New York ( August 4, 2011, 1:57 PM EDT) -- In a long-awaited decision issued July 29, 2011, the federal appeals court responsible for patent matters reversed a lower court decision that had threatened to eliminate all "gene patents." In the case of Association for Molecular Pathology v. Myriad Genetics a three-judge panel of the Court of Appeals for the Federal Circuit in large part overturned a New York federal district court decision from last April. The suit had been brought by several medical societies, physicians and individual cancer patients, seeking to invalidate several so-called "gene patents" held by Myriad Genetics and the University of Utah....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.